American Academy of Neurology 2025 (AAN)

Back

Safety and Efficacy of DYNE-101 in Adults with DM1: Phase 1/2 ACHIEVE Trial Data (presentation)

View

Safety and Efficacy of DYNE-251 in Males with DMD Mutations Amenable to Exon 51 Skipping (presentation)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.